{"id":565890,"date":"2026-09-11T02:00:00","date_gmt":"2026-09-11T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/o-iptacopan-e-o-pegcetacoplan-abrem-novos-horizontes\/"},"modified":"2026-09-16T22:48:12","modified_gmt":"2026-09-16T20:48:12","slug":"o-iptacopan-e-o-pegcetacoplan-abrem-novos-horizontes","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/o-iptacopan-e-o-pegcetacoplan-abrem-novos-horizontes\/","title":{"rendered":"O Iptacopan e o Pegcetacoplan abrem novos horizontes"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Para diagnosticar uma glomerulopatia C3 (C3G) e diferenci\u00e1-la de outras glomerulopatias membranoproliferativas, \u00e9 necess\u00e1ria, para al\u00e9m da determina\u00e7\u00e3o da concentra\u00e7\u00e3o da prote\u00edna C3 do complemento no sangue, uma bi\u00f3psia renal. Atrav\u00e9s de exames ao microsc\u00f3pio eletr\u00f3nico e de imunofluoresc\u00eancia, \u00e9 poss\u00edvel identificar dep\u00f3sitos de complemento. Estudos cl\u00ednicos demonstraram que os inibidores do complemento oferecem um grande potencial terap\u00eautico. Destacam-se, em particular, o iptacopan e o pegcetacoplan \u2014 ambos os inibidores do complemento obtiveram este ano, tamb\u00e9m na Su\u00ed\u00e7a, uma extens\u00e3o da indica\u00e7\u00e3o para a C3G.<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fo-iptacopan-e-o-pegcetacoplan-abrem-novos-horizontes%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Para diagnosticar uma glomerulopatia C3 (C3G) e diferenci\u00e1-la de outras glomerulopatias membranoproliferativas, \u00e9 necess\u00e1ria, para al\u00e9m da determina\u00e7\u00e3o da concentra\u00e7\u00e3o da prote\u00edna C3 do complemento no sangue, uma bi\u00f3psia renal&#8230;.&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fo-iptacopan-e-o-pegcetacoplan-abrem-novos-horizontes%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":565898,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Glomerulopatia C3 \u2013 ser\u00e1 poss\u00edvel travar a sua progress\u00e3o?     ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11521,11305,11426,11529],"tags":[100979,54571,100984,100982,100977,100978,29054,100976,100980,100981,74346,100983],"powerkit_post_featured":[],"class_list":["post-565890","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-estudos","category-medicina-interna-geral","category-nefrologia-pt-pt","category-relatorios-do-congresso","tag-aspaveli","tag-biopsia-aos-rins","tag-c3g","tag-fabhalta","tag-glomerulopatia","tag-glomerulopatia-c3","tag-imunofluorescencia","tag-inibidores-do-complemento-2","tag-iptacopan","tag-pegcetacoplan","tag-progressao-pt-pt","tag-proteina-do-complemento","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-24 13:57:25","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":565901,"slug":"el-iptacopan-y-el-pegcetacoplan-abren-nuevos-horizontes","post_title":"El iptacop\u00e1n y el pegcetacoplan abren nuevos horizontes","href":"https:\/\/medizinonline.com\/es\/el-iptacopan-y-el-pegcetacoplan-abren-nuevos-horizontes\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/565890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=565890"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/565890\/revisions"}],"predecessor-version":[{"id":565929,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/565890\/revisions\/565929"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/565898"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=565890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=565890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=565890"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=565890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}